EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparison of the telephone‐Montreal Cognitive Assessment (T‐MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease

Sheridan D Chappelle, Christina Gigliotti, Gabriel C Léger, Guerry M Peavy, Diane M Jacobs, Sarah J Banks, Emily A Little, Douglas Galasko, David P Salmon

Alzheimer's & Dementia · 2023-10 · 19 (10) · 4599-4608

DOI: 10.1002/alz.13039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 20.03.2023. Verfasst von Sheridan D Chappelle und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shiley-Marcos Alzheimer's Disease Research Center, Department of Neurosciences, University of California, San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Remote screening for cognitive impairment associated with Alzheimer's disease (AD) has grown in importance with the expected rise in prevalence of AD in an aging population and with new potential treatment options.

Methods

The Telephone Interview for Cognitive Status (TICS) and new telephone adaptation of the Montreal Cognitive Assessment (T‐MoCA) were administered to participants independently classified through in‐person clinical evaluation as cognitively normal (CN; n = 167), mild cognitive impairment (MCI; n = 25), or dementia ( n = 23). Cerebrospinal fluid AD biomarkers were measured ( n = 79).

Results

TICS and T‐MoCA were highly correlated ( r = 0.787; P < 0.001): groups differed on both (CN

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHumansAgedAmyloid beta-PeptidesNeuropsychological TestsMental Status and Dementia TestsTelephoneCognitionBiomarkers

Stichwörter der Autor:innen

Alzheimer's diseasecognitioncognitive screeningmild cognitive impairmentremote cognitive assessment

Substanzen

Amyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Shiley-Marcos Alzheimer's Disease Research Center, Department of Neurosciences, University of California, San Diego, La Jolla, California, USA.

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Chappelle, S. D., Gigliotti, C., Léger, G. C., Peavy, G. M., Jacobs, D. M., Banks, S. J., Little, E. A., Galasko, D., & Salmon, D. P. (2023). Comparison of the telephone‐Montreal Cognitive Assessment (T‐MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease. Alzheimer's & Dementia, 19(10), 4599-4608. https://doi.org/10.1002/alz.13039

Vancouver

Chappelle SD, Gigliotti C, Léger GC, Peavy GM, Jacobs DM, Banks SJ, et al. Comparison of the telephone‐Montreal Cognitive Assessment (T‐MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease. Alzheimer's & Dementia. 2023;19(10):4599-4608. doi:10.1002/alz.13039

BibTeX
@article{Chappelle2023,
  author = {Chappelle, Sheridan D and Gigliotti, Christina and Léger, Gabriel C and Peavy, Guerry M and Jacobs, Diane M and Banks, Sarah J and Little, Emily A and Galasko, Douglas and Salmon, David P},
  title = {Comparison of the telephone‐Montreal Cognitive Assessment (T‐MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {10},
  pages = {4599--4608},
  doi = {10.1002/alz.13039}
}
Kostenlos starten →